脑梗死出血转化后继续阿司匹林抗血小板聚集治疗的效果

发布时间：2018-05-30 11:19

  本文选题：脑梗死 + 出血转化　； 参考：《临床医学工程》2016年12期

【摘要】：目的探讨脑梗死出血转化后继续服用阿司匹林临床抗血小板聚集的效果。方法选取我院2013年1月至2015年12月期间120例急性脑梗死入院治疗出现出血症状的患者,按双盲法随机分为实验组60例、对照组60例。在给予相应对症治疗的同时,实验组继续使用阿司匹林,对照组停止服用抗血小板聚集药物并在出血稳定后继续启用。结果治疗后,实验组较对照组纤维蛋白水平指标恢复好(P0.05),经头颅CT检查显示两组的脑出血量均未见明显增加(P0.05)。治疗前和治疗3个月后,两组神经损伤程度比较无统计学差异(P0.05);治疗1个月后,实验组的神经损伤程度评分显著低于对照组(P0.05)。结论对脑梗死出血转化患者,临床发现出血后继续使用阿司匹林抗血小板治疗,有利于神经功能恢复和血液流变学指标恢复。
[Abstract]:Objective to investigate the effect of aspirin on platelet aggregation after cerebral infarction. Methods from January 2013 to December 2015, 120 patients with acute cerebral infarction were randomly divided into experimental group (n = 60) and control group (n = 60). While the corresponding symptomatic treatment was given, the experimental group continued to use aspirin, while the control group stopped taking the antiplatelet aggregation drug and continued to use it after the bleeding stabilized. Results after treatment, the fibrin level of the experimental group recovered better than that of the control group (P0.05A), and the cerebral hemorrhage volume of the two groups was not significantly increased by CT examination. There was no significant difference in the degree of nerve injury between the two groups before and after 3 months of treatment, but after one month of treatment, the score of nerve injury in the experimental group was significantly lower than that in the control group (P 0.05). Conclusion Aspirin antiplatelet therapy is beneficial to the recovery of nerve function and hemorheology in patients with cerebral infarction.
【作者单位】： 广东省高州市人民医院;
【分类号】：R743.33
，

本文编号：1955116